News and Publications?height=270

News & publications

Related news & insights - Rachel Bradley

Associated Press and Open AI: the first news-sharing and technology partnership
Posted: 26/10/2023
The two-year partnership between the Associated Press (AP) and OpenAI, the parent company of ChatGPT, is one that has the potential to influence the way developers access and exploit valuable data sets to train AI. Whilst some of the key details of the deal have not been disclosed, including the commercial terms, what has been shared is that......>>
Is student-created IP fair game?
Posted: 26/04/2023
Is it fair for a university to own intellectual property (IP) created by a student? In the recent ruling of OUI v ONI, Judge Daniel Alexander clarified a key legal issue in relation to postgraduate students as consumers, and its impact on university IP policies. The case arose against a background of debate amongst higher educational institutions......>>
Comparing the EU clinical trials regulation and the MHRA consultation on clinical trials
Posted: 23/05/2022
Life sciences analysis: Rachel Bradley, partner, and Shaan Mehra and Clemency Pleming, trainee solicitors, explain the key provisions of the new EU Clinical Trials Regulation and considers how these compare with the main proposals in the MHRA’s consultation on the UK clinical trials regime......>>
What MHRA medical devices regulation consultation seeks to address
Posted: 08/12/2021
On 16 September 2021, the Medicines and Healthcare products Regulatory Agency (MHRA) published its open consultation on the future regulation of medical devices in the United Kingdom (the consultation). Its objective is to update the Medical Devices Regulations 2002 (the regulation) that currently set out the regulatory framework for medical devices......>>
Regulation of GMOs: time to modify the law?
Posted: 26/08/2021
At an Environmental Audit Committee meeting in June 2020, the UK Secretary of State for Environment, Food and Rural Affairs, George Eustice, offered his support for gene editing after Brexit, saying that the UK Government disagrees with the EU’s stance on the matter......>>
Penningtons Manches Cooper advises Oxford Cannabinoid Technologies Holdings plc on its main market IPO
Posted: 21/05/2021
Penningtons Manches Cooper has advised Oxford Cannabinoid Technologies Holdings plc (OCTP) on its initial public offering (IPO) on the London Stock Exchange, which valued the company at £48 million. The standard listing on London’s main market involved a £16.5 million placing with admission occurring this morning...…>>
Illumina Cambridge Limited v Latvia MGI Tech SIA & Others – the “chocolate teapot” theory
Posted: 21/04/2021
Earlier this year, Mr Justice Birss handed down his judgment in the case of Illumina Cambridge Limited v Latvia MGI Tech SIA & Others [2021] EWHC 57 (Pat). The judgment is the first application of the sufficiency principles set out in the Supreme Court’s landmark decision in Regeneron Pharmaceuticals Inc v Kymab Ltd [2020] UKSC 27......>>

Filter news & insights

Filter by keyword: Filter by expertise:

In this section

Media enquiries

Contact our press team on:

+44 (0)20 7457 3258
+44 (0)7887 888105 (out of hours)

Useful links

Value

Contact an office

London (Head office)
+44 (0)20 7457 3000
Basingstoke
+44 (0)1256 407100
Birmingham
+44 (0)121 312 2560
Cambridge
+44 (0)1223 465465
Guildford
+44 (0)1483 791800
Oxford
+44 (0)1865 722106
Reading
+44 (0)118 982 2640

Madrid
+34 91 781 6670
Paris
+33 1 44 34 24 80
Piraeus
+30 210 361 4840
Singapore
+65 6438 4497

Sectors

Services for Business

Services for Individuals

Copyright

© 2023 Penningtons Manches Cooper LLP.
All rights reserved.
Website design by Frontmedia / Dynamic Pear

Penningtons Manches Cooper LLP

Penningtons Manches Cooper LLP is a limited liability partnership registered in England and Wales with registered number OC311575 and is authorised and regulated by the Solicitors Regulation Authority under number 419867.